Matteo Spaziani, Chiara Tarantino, Natascia Tahani, Daniele Gianfrilli, Emilia Sbardella, Andrea M Isidori, Andrea Lenzi, Antonio F Radicioni

Frontiers in Endocrinology 2021, 12: 634288

doi: 10.3389/fendo.2021.634288

Julian W Sacre, Dianna J Magliano, Jonathan E Shaw

Diabetes & Metabolism 2021 March 17, : 101249

https://doi.org/10.1016/j.diabet.2021.101249

Published:March, 2021

DOI:https://doi.org/10.1016/S2468-1253(20)30331-9

Nutrición Hospitalaria 03536 / http://dx.doi.org/10.20960/nh.03536

VOLUMEN 38, NÚM. 1, enero-febrero (2021), PAG. 1-217

Best Pract Res Clin Endocrinol Metab. 2021 Feb 6;101491.

PMID: 33593680

DOI: 10.1016/j.beem.2021.101491

Published Online:23 Dec 2020

https://doi.org/10.1089/thy.2020.0555

Abstract

Background: Refining the risk of malignancy in patients presenting with thyroid nodules with indeterminate cytology (IC) is a critical challenge. We investigated the performances of 18F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) to predict malignancy.

Nature Metabolism (2021)

Published: 03 February 2021

Nutrients 2020, 12(10), 2956; 

https://doi.org/10.3390/nu12102956